Literature DB >> 3231905

Mast cells in bronchoalveolar lavage in sarcoidosis: correlation with alveolar lymphocytes.

P Rottoli1, L Rottoli, M G Perari, A Collodoro, G Carriero, S Bianco.   

Abstract

Today it is believed that mast cells (MC) are important not only in IgE-mediated reactions, but also in delayed hypersensitivity reactions, and that their functions are mediated by factors released by T lymphocytes. Recent studies have shown their presence in bronchoalveolar lavage (BAL) of patients with asthma and interstitial lung disease. MC have been identified by us in the BAL of patients with sarcoidosis and lung cancer, and in controls. A statistically significant correlation has been found between MC and lymphocytes, CD3+ and CD4+ cells present in BAL, thus supporting the hypothesis of interactions between T lymphocytes and MC in immune reactions at the alveolar level.

Entities:  

Mesh:

Year:  1988        PMID: 3231905     DOI: 10.1159/000195476

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  4 in total

1.  T cell dominated inflammatory reactions in the bronchioles of asymptomatic asthmatics are also present in the nasal mucosa.

Authors:  L W Poulter; A Norris; C Power; A Condez; H Burnes; B Schmekel; C Burke
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

2.  The analysis of tryptase in serum of sarcoidosis patients.

Authors:  Elena Bargagli; Angela Mazzi; Fabrizio Mezzasalma; Anna Perrone; Carmela Olivieri; Antje Prasse; Nicola Bianchi; Maria G Pieroni; Paola Rottoli
Journal:  Inflammation       Date:  2009-10       Impact factor: 4.092

3.  Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis.

Authors:  Vyacheslav Palchevskiy; Nastran Hashemi; Stephen S Weigt; Ying Ying Xue; Ariss Derhovanessian; Michael P Keane; Robert M Strieter; Michael C Fishbein; Jane C Deng; Joseph P Lynch; Robert Elashoff; John A Belperio
Journal:  Fibrogenesis Tissue Repair       Date:  2011-04-04

4.  Changes in lung immune cells related to clinical outcome during treatment with infliximab for sarcoidosis.

Authors:  S Kullberg; N V Rivera; M Abo Al Hayja; J Grunewald; A Eklund
Journal:  Clin Exp Immunol       Date:  2020-04-22       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.